Plastic Segment to Lead Blood Collection Tubes for Liquid Biopsy Market During 2021–2028
According to our latest study on "Blood Collection Tubes for Liquid Biopsy Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Product (ccfDNA Tubes, cfRNA Tubes, CTC Tubes, gDNA Tubes, Intracellular RNA Tubes, and Others); Material (Glass and Plastic); Application (In-Vitro Diagnostics (IVD) and Research); End User (Genetic Diagnostic Labs, R&D Centers, Conventional Diagnostic Centers, and Others)," the market is expected to grow from US$ 79.03 million in 2021 to US$ 256.26 million by 2028; it is estimated to register a CAGR of 18.3% from 2021 to 2028. The report highlights the key factors driving the market and prominent players with their developments. The growth of the blood collection tubes for liquid biopsy market is primarily attributed due to the increasing prevalence of cancer and rising demand for minimally invasive diagnostic tests. However, the lack of skilled professionals leading to inaccurate blood collection for liquid biopsy analysis can hamper the market growth.
The demand for blood collection tubes for liquid biopsy decreased upon the onset of the COVID-19 pandemic in 2020. The unprecedented impact of COVID-19 has been far-reaching, and it is claimed to have a more severe impact on cancer patients. The restrictive measures imposed to lower the infection rate have profoundly limited the number of patients undergoing cancer screening, diagnosis, and treatment. Moreover, a surge in pressure due to the growing rate of hospitalization among COVID-19 patients led to the re-profiling of many hospitals and healthcare departments, including oncology clinics, for treating such patients. According to one of the studies, many diagnostic and treatment procedures were canceled or postponed in the world, which included ~2.3 million cancer surgeries.
Based on product, the blood collection tubes for liquid biopsy market is segmented into ccfDNA Tubes, cfRNA tubes, CTC tubes, gDNA tubes, intracellular RNA tubes, and others. The ccfDNA segment held the largest share of the market in 2021; moreover, it is anticipated to register the highest CAGR of 18.9% in the market during the forecast period. The ccfDNA tube is used to collect, store, and transport venous whole blood, as well as to stabilize DNA for extraction, cell-free DNA (ccfDNA) from plasma and genomic DNA (gDNA) from the nucleated cellular fraction. Clinical laboratories can use the ccfDNA tube to stabilize samples when they can't be processed on the same day of collection.
PreAnalytix GmbH; Biocept, Inc.; F. Hoffmann-La Roche Ltd.; STRECK; Norgen Biotek Corp; Exact Sciences Corporation; Greiner AG; MagBio Genomics, Inc.; Zymo Research Corporation; Apostle Sciences are a few of the leading companies operating in the blood collection tubes for liquid biopsy market.
Blood Collection Tubes for Liquid Biopsy Market, by Geography, 2021 (%)
Blood Collection Tubes for Liquid Biopsy Market Growth | 2028
Download Free Sample
Blood Collection Tubes for Liquid Biopsy Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (ccfDNA Tubes, cfRNA Tubes, CTC Tubes, gDNA Tubes, Intracellular RNA Tubes, and Others), Material (Glass and Plastic), Application [In-Vitro Diagnostics (IVD) and Research], End User (Genetic Diagnostic Labs, R&D Centers, Conventional Diagnostic Centers, and Others)
Blood Collection Tubes for Liquid Biopsy Market Growth | 2028
Download Free SampleBlood Collection Tubes for Liquid Biopsy Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (ccfDNA Tubes, cfRNA Tubes, CTC Tubes, gDNA Tubes, Intracellular RNA Tubes, and Others), Material (Glass and Plastic), Application [In-Vitro Diagnostics (IVD) and Research], End User (Genetic Diagnostic Labs, R&D Centers, Conventional Diagnostic Centers, and Others)
The report segments the blood collection tubes for liquid biopsy market as follows:
The blood collection tubes for liquid biopsy market is segmented on the basis of product, material, application, end user, and geography. Based on product, the market is subsegmented into ccfDNA tubes, cfRNA tubes, CTC tubes, gDNA tubes, intracellular RNA tubes, and others. Based on material, the market is bifurcated into glass and plastic. The blood collection tubes for liquid biopsy market, by application, is further segmented into in-vitro diagnostics (IVD) and research. The market, based on end user, is subsegmented into genetic diagnostic labs, R&D centers, conventional diagnostic centers, and others. In terms of geography, the blood collection tubes for liquid biopsy market is segmented into North America (US, Canada, and Mexico), Europe (UK, Germany, France, Italy, Spain, and Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and Rest of Asia Pacific), the Middle East & Africa (UAE, Saudi Arabia, Africa, and Rest of the Middle East & Africa), and South and Central America (Brazil, Argentina, and Rest of South and Central America).
Contact Us
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com